Skip to main content

Theriva Biologics, Inc.

TOVX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000894158

No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.

Members of Congress who traded TOVX

No member of Congress has reported a trade in Theriva Biologics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.